A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis—Can We Draw a Line?

Idiosyncratic drug-induced liver injury (DILI) is an unpredictable reaction of individuals exposed to a certain drug, and drug-induced autoimmune hepatitis (DIAIH) presents a DILI phenotype that mimics idiopathic autoimmune hepatitis (AIH) when considering the clinical, biochemical, serological and...

Full description

Bibliographic Details
Main Authors: Dorotea Božić, Ante Tonkić, Katarina Vukojevic, Maja Radman
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Clinics and Practice
Subjects:
Online Access:https://www.mdpi.com/2039-7283/13/6/125
_version_ 1797381561399640064
author Dorotea Božić
Ante Tonkić
Katarina Vukojevic
Maja Radman
author_facet Dorotea Božić
Ante Tonkić
Katarina Vukojevic
Maja Radman
author_sort Dorotea Božić
collection DOAJ
description Idiosyncratic drug-induced liver injury (DILI) is an unpredictable reaction of individuals exposed to a certain drug, and drug-induced autoimmune hepatitis (DIAIH) presents a DILI phenotype that mimics idiopathic autoimmune hepatitis (AIH) when considering the clinical, biochemical, serological and histological parameters. We present a case report of a 48-year-old male who was hospitalized due to severe hepatocellular liver injury two months after self-treatment with a muscle-building dietary supplement based on arginine-alpha-ketoglutarate, L-citrulline, L tyrosine, creatine malate and beet extract. His immunology panel was positive with increased IgG levels, and radiologic methods showed no signs of chronic liver disease. He underwent corticosteroid treatment with adequate response. After therapy withdrawal, a clinical relapse occurred. Seven months after the initial presentation, liver MR suggested initial cirrhotic changes in the right liver lobe. A liver biopsy revealed abundant lymphoplasmacytic infiltrate with piecemeal necrosis and grade 2 fibrosis. He responded well to the corticosteroid treatment again, and was further treated with low-dose prednisone without additional relapses. Several years later, further management confirmed the presence of liver cirrhosis with no histological or biochemical signs of disease activity. DIAIH is a DILI phenotype that is difficult to distinguish from idiopathic AIH despite a wide armamentarium of diagnostic methods. It should always be considered among the differential diagnoses in patients presenting with hepatocellular liver injury.
first_indexed 2024-03-08T20:54:15Z
format Article
id doaj.art-f80737212b1b42ebabfeec3bafe4c8f6
institution Directory Open Access Journal
issn 2039-7283
language English
last_indexed 2024-03-08T20:54:15Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Clinics and Practice
spelling doaj.art-f80737212b1b42ebabfeec3bafe4c8f62023-12-22T14:00:59ZengMDPI AGClinics and Practice2039-72832023-11-011361393139910.3390/clinpract13060125A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis—Can We Draw a Line?Dorotea Božić0Ante Tonkić1Katarina Vukojevic2Maja Radman3Department of Gastroenterology, University Hospital of Split, Spinčićeva 1, 21000 Split, CroatiaDepartment of Endocrinology, University Hospital of Split, Spinčićeva 1, 21000 Split, CroatiaDepartment of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, CroatiaDepartment of Endocrinology, University Hospital of Split, Spinčićeva 1, 21000 Split, CroatiaIdiosyncratic drug-induced liver injury (DILI) is an unpredictable reaction of individuals exposed to a certain drug, and drug-induced autoimmune hepatitis (DIAIH) presents a DILI phenotype that mimics idiopathic autoimmune hepatitis (AIH) when considering the clinical, biochemical, serological and histological parameters. We present a case report of a 48-year-old male who was hospitalized due to severe hepatocellular liver injury two months after self-treatment with a muscle-building dietary supplement based on arginine-alpha-ketoglutarate, L-citrulline, L tyrosine, creatine malate and beet extract. His immunology panel was positive with increased IgG levels, and radiologic methods showed no signs of chronic liver disease. He underwent corticosteroid treatment with adequate response. After therapy withdrawal, a clinical relapse occurred. Seven months after the initial presentation, liver MR suggested initial cirrhotic changes in the right liver lobe. A liver biopsy revealed abundant lymphoplasmacytic infiltrate with piecemeal necrosis and grade 2 fibrosis. He responded well to the corticosteroid treatment again, and was further treated with low-dose prednisone without additional relapses. Several years later, further management confirmed the presence of liver cirrhosis with no histological or biochemical signs of disease activity. DIAIH is a DILI phenotype that is difficult to distinguish from idiopathic AIH despite a wide armamentarium of diagnostic methods. It should always be considered among the differential diagnoses in patients presenting with hepatocellular liver injury.https://www.mdpi.com/2039-7283/13/6/125drug-induced autoimmune hepatitisAIHDILIacute hepatitis
spellingShingle Dorotea Božić
Ante Tonkić
Katarina Vukojevic
Maja Radman
A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis—Can We Draw a Line?
Clinics and Practice
drug-induced autoimmune hepatitis
AIH
DILI
acute hepatitis
title A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis—Can We Draw a Line?
title_full A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis—Can We Draw a Line?
title_fullStr A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis—Can We Draw a Line?
title_full_unstemmed A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis—Can We Draw a Line?
title_short A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis—Can We Draw a Line?
title_sort case report idiopathic or drug induced autoimmune hepatitis can we draw a line
topic drug-induced autoimmune hepatitis
AIH
DILI
acute hepatitis
url https://www.mdpi.com/2039-7283/13/6/125
work_keys_str_mv AT doroteabozic acasereportidiopathicordruginducedautoimmunehepatitiscanwedrawaline
AT antetonkic acasereportidiopathicordruginducedautoimmunehepatitiscanwedrawaline
AT katarinavukojevic acasereportidiopathicordruginducedautoimmunehepatitiscanwedrawaline
AT majaradman acasereportidiopathicordruginducedautoimmunehepatitiscanwedrawaline
AT doroteabozic casereportidiopathicordruginducedautoimmunehepatitiscanwedrawaline
AT antetonkic casereportidiopathicordruginducedautoimmunehepatitiscanwedrawaline
AT katarinavukojevic casereportidiopathicordruginducedautoimmunehepatitiscanwedrawaline
AT majaradman casereportidiopathicordruginducedautoimmunehepatitiscanwedrawaline